Please use this identifier to cite or link to this item:
|Title:||Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells|
|Authors:||Chatterjee, D.K. |
|Keywords:||HT29 cell line|
Upconversion wistar rats
|Citation:||Chatterjee, D.K., Yong, Z. (2008-02). Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine 3 (1) : 73-82. ScholarBank@NUS Repository. https://doi.org/10.2217/174358188.8.131.52|
|Abstract:||Background: Photodynamic therapy (PDT) involves killing of diseased cells by excitation of photosensitizer chemicals with high-energy light to produce cytotoxic oxygen species from surrounding dissolved oxygen. However, poor tissue penetration of high-energy light and hydrophobic photosensitizers limits the effectiveness to superficial pathologies. Upconversion phosphor nanoparticles convert low-energy radiation to higher-energy emissions. Aim: To create upconverting 'nanotransducers' to enable PDT in deep tissues. Results: Monodisperse, 50 nm PEI/NaYP4:Yb3+,Er3+ nanoparticles producing green/red emission on near-infrared (NIR) excitation were targeted to folate receptors on human colon cancer cells and imaged with high signal-to-background ratio. It was demonstrated that these particles could be excited after deep intramuscular injection in rats. On NIR excitation, the particles, modified with zinc phthalocyanin photosensitizer, released singlet oxygen and, after targeted binding to cancer cells, resulted in significant cell destruction. Conclusion: Potential clinical use of these nanoparticles includes imaging and PDT of cancer in deep tissues. © 2008 Future Medicine Ltd.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 21, 2018
WEB OF SCIENCETM
checked on Jun 12, 2018
checked on Jul 6, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.